Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives ; volume:4 ; number:1 ; day:19 ; month:10 ; year:2023 ; pages:1-14 ; date:12.2023
Implementation science communications ; 4, Heft 1 (19.10.2023), 1-14, 12.2023
- Urheber
-
Koester, Kimberly A.
Colasanti, Jonathan A.
McNulty, Moira C.
Dance, Kaylin
Erguera, Xavier A.
Tsuzuki, Manami Diaz
Johnson, Mallory O.
Sauceda, John A.
Montgomery, Elizabeth
Schneider, John
Christopoulos, Katerina A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43058-023-00506-3
- URN
-
urn:nbn:de:101:1-2024020908113737826032
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koester, Kimberly A.
- Colasanti, Jonathan A.
- McNulty, Moira C.
- Dance, Kaylin
- Erguera, Xavier A.
- Tsuzuki, Manami Diaz
- Johnson, Mallory O.
- Sauceda, John A.
- Montgomery, Elizabeth
- Schneider, John
- Christopoulos, Katerina A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Co-designing strategies to implement long-acting injectable PrEP for sexual minority men in Chicago: a study protocol for an innovation tournament and implementation mapping
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Assessing the Readiness of Rural Public Librarians to Implement Public Health Programs
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Co-designing strategies to implement long-acting injectable PrEP for sexual minority men in Chicago: a study protocol for an innovation tournament and implementation mapping
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Assessing the Readiness of Rural Public Librarians to Implement Public Health Programs
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Co-designing strategies to implement long-acting injectable PrEP for sexual minority men in Chicago: a study protocol for an innovation tournament and implementation mapping
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Assessing the Readiness of Rural Public Librarians to Implement Public Health Programs